The biopharmaceutical manufacturing sector is currently grappling with a legacy of outdated, fragmented quality control methods that create significant production delays and impose a staggering financial burden on the industry. These traditional, off-line testing protocols, which often rely on
The European health sector is currently navigating a period of unprecedented transformation, where landmark legislative reforms and a surge in therapeutic innovation are converging to redefine the future of medicine regulation. As the European Medicines Agency (EMA) marks its 30th anniversary, it
The intersection of artificial intelligence and synthetic biology has unlocked groundbreaking possibilities, but it also casts a dark shadow over global biosecurity, as highlighted in a pivotal study recently published in Science . This research reveals how AI-powered generative protein design
Imagine a world where a single line of code or a novel genetic sequence, crafted by artificial intelligence, could slip past all safety nets and enable the creation of a deadly pathogen, posing a grave threat to global security. This chilling scenario is no longer confined to science fiction but
In a significant stride toward shaping the future of biotechnology in Ghana, the recent inauguration of the fourth Governing Board of the National Biosafety Authority (NBA) in Accra has sparked renewed optimism about the nation’s potential to lead in biosafety governance, marking a critical
Taiwan is carving out a formidable reputation in the global biotech arena, and its participation in BioJapan 2025, taking place from October 8-10 at PACIFICO Yokohama in Yokohama, Japan, is a testament to this ascent. Led by the Biotechnology and Pharmaceutical Industries Promotion Office (BPIPO),
